PDX1 and familial pancreatic carcinoma: We previously showed that a CCK receptor antagonist, proglumide, prevents fibrosis in the pancreas extracellular matrix in Pdx1-Cre/LSL-KrasG12D transgenic mice [25] and also decreased the fibrosis in models of pancreatic cancer [38,39].